Farmaceutische Technologie en Biofarmacie

Telefoon+31 50 363 3284, +31 50 363 2500

Postal addressToon op kaart
A Deusinglaan1
9713 AV Groningen
Netherlands

Julia Berends
- julia.berendsrugnl
- Faculty of Science and Engineering, Farmaceutische Technologie en Biofarmacie - Promovendus
Persoon: Wetenschappelijk Personeel
Carin Biel, MSc
- C.Bielrugnl
- Faculty of Science and Engineering, Farmaceutische Technologie en Biofarmacie - Externe medewerker
Persoon: Wetenschappelijk Personeel
Anne de Boer
- A.H.de.Boerrugnl
- Faculty of Science and Engineering, Farmaceutische Technologie en Biofarmacie - Onderzoeker
Persoon: Wetenschappelijk Personeel

A Single Injection with Sustained-Release Microspheres and a Prime-Boost Injection of Bovine Serum Albumin Elicit the Same IgG Antibody Response in Mice
van der Kooij, R. S., Beukema, M., Huckriede, A. L. W., Zuidema, J., Steendam, R., Frijlink, H. W. & Hinrichs, W. L. J., 16-feb.-2023, In: Pharmaceutics. 15, 2, 23 blz., 676.
Onderzoeksoutput › Academic › peer review

Open Access
Bestand

15 Downloads (Pure)
Capsules with Ileocolonic-Targeted Release of Vitamin B2, B3, and C (ColoVit) Intended for Optimization of Gut Health: Development and Validation of the Production Process
Ahmed, A. A., Otten, A. T., Gareb, B., Huijmans, J. E., Eissens, A. C., Rehman, A., Dijkstra, G., Kosterink, J. G. W., Frijlink, H. W. & Schellekens, R. C. A., 28-apr.-2023, In: Pharmaceutics. 15, 5, 20 blz., 1354.
Onderzoeksoutput › Academic › peer review

Open Access
Bestand

12 Downloads (Pure)
Clinical Validation of a Capillary Blood Home-Based Self-Sampling Technique for Monitoring of Infliximab, Vedolizumab, and C-Reactive Protein Concentrations in Patients With Inflammatory Bowel Disease
Otten, A. T., van der Meulen, H. H., Steenhuis, M., Loeff, F. C., Touw, D. J., Kosterink, J. G. W., Frijlink, H. W., Rispens, T., Dijkstra, G., Visschedijk, M. C. & Bourgonje, A. R., 2-jun.-2023, (E-pub ahead of print) In: Inflammatory Bowel Diseases.
Onderzoeksoutput › Academic › peer review

Open Access
Bestand

19 Downloads (Pure)

10 Professional or public presentation
9 Academic presentation
3 Organising and contributing to an event
2 Attending an event
Meer
- 2 Editorial work
- 1 Membership

Ziekmakers en betermakers
Toos Daemen (Invited speaker), Marjolein Irwin-Knoester (Invited speaker) & Erik Frijlink (Invited speaker)
12-jan.-2023
Activiteit: Professional or public presentation › Popular
2022 ISV Annual Congress
Rick Heida (Contributor)
18-sep.-2022 → 20-sep.-2022
Activiteit: Academic presentation › Academic
PUF Academy
Paul Hagedoorn (Invited speaker)
12-nov.-2020
Activiteit: Professional or public presentation › Professional

Dataset: Ovalbumin-containing core-shell implants suitable to obtain a delayed IgG1 antibody response in support of a biphasic pulsatile release profile in mice
Amssoms, K. (Creator), Born, P. (Creator), Beugeling, M. (Creator), De Clerck, B. (Creator), Van Gulck, E. (Creator), Hinrichs, W. (Creator), Frijlink, E. (Creator), Grasmeijer, N. (Creator), Kraus, G. (Creator), Sutmuller, R. (Creator), Simmen, K. (Creator) & Baert, L. (Creator), University of Groningen, 17-aug.-2018
DOI: 10.6084/m9.figshare.6979778.v1
Dataset

Een vaccinatie inademen: in China kan het, hier straks ook?
Henderik Frijlink
23/12/2022
1 item van Media-aandacht
Pers / media: Expert Comment › Popular
Beter om niet te wisselen van voorzetkamer
Paul Hagedoorn
01/06/2022
1 item van Media-aandacht
Pers / media: Expert Comment › Popular
Oplossing voor niet langer leverbare Rhinocort Turbuhaler
Paul Hagedoorn
01/02/2020
1 Mediabijdrage
Pers / media: Activiteiten met een maatschappelijk belang › Professional

2020 EJPB Most Cited Paper Award
Frijlink, Erik (Recipient), Hinrichs, Wouter (Recipient), Mensink, Maarten (Recipient) & van der Voort Maarschalk, Kees (Recipient), 23-mrt.-2021
Prijs: Prize › Academic
The Utrecht University Award for Excellence in Pharmaceutical Research
Frijlink, Erik (Recipient), 2015
Prijs: Prize › Academic
Wubbo Ockels Price
Frijlink, Erik (Recipient), 2010
Prijs: Prize › Academic